No Data
No Data
Fulcrum Therapeutics Faces Genzyme Agreement Termination
Express News | Fulcrum Therapeutics Inc - Sanofi to Terminate Collaboration and License Agreement With Fulcrum
Fulcrum Therapeutics Rumor Highlighted in Betaville Alert
Express News | Shares Of Fulcrum Therapeutics See Volume; Traders Circulating Co. Mentioned By M&A Blog
Fulcrum Therapeutics (NASDAQ:FULC) Shareholders Have Endured a 77% Loss From Investing in the Stock Three Years Ago
Subdued Growth No Barrier To Fulcrum Therapeutics, Inc. (NASDAQ:FULC) With Shares Advancing 32%